Monte Rosa Therapeutics Inc

GLUE

Company Profile

  • Business description

    Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their most advanced product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.

  • Contact

    321 Harrison Avenue
    Suite 900
    BostonMA02118
    USA

    T: +1 617 949-2643

    https://www.monterosatx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    103

Stocks News & Analysis

stocks

What next for the largest company on the ASX?

After a historic rally in 2024, what lies ahead for this overvalued banking titan?
stocks

Ask the analyst: Are IDP Education's woes temporary?

The global education services provider has gone from stock market darling to one of the ASX's weakest performers. What gives?
stocks

Is it time to buy the Magnificent Seven?

After the recent selloff, the bull market’s most in-demand stocks look much cheaper.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,013.3046.700.59%
CAC 408,028.2890.071.13%
DAX 4022,986.82419.681.86%
Dow JONES (US)41,488.19674.621.65%
FTSE 1008,632.3389.771.05%
HKSE23,959.98497.332.12%
NASDAQ17,754.09451.072.61%
Nikkei 22537,053.10263.070.72%
NZX 50 Index12,266.2557.200.47%
S&P 5005,638.94117.422.13%
S&P/ASX 2007,789.7040.600.52%
SSE Composite Index3,419.5660.831.81%

Market Movers